Skip to main content
SMX
NASDAQ Technology

SMX Expands Equity Plan by 94%, Grants RSUs Representing Over 30% Potential Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Negative
Importance info
9
Price
$2.35
Mkt Cap
$9.9M
52W Low
$1.65
52W High
$27,493.802
52W Position info
42% above low
Off High info
100% below high
Rel. Volume info
6.6× avg
Market data snapshot near publication time

SMX sits 42% above its 52-week low of $1.65 on elevated volume (6.6× avg).

Summary

SMX significantly expanded its incentive equity plan and granted 2.3 million restricted stock units to executives and directors, potentially diluting existing shareholders by over 30%.


Key Events · Financing and Capital Events · SMX

  • Incentive Plan Expansion

    The 2022 Incentive Equity Plan was amended, increasing the authorized shares from 2,442,092 to 4,754,592, an increase of 2,312,500 shares.

  • Significant RSU Grants

    An aggregate of 2,300,000 restricted stock units were granted to executive officers, directors, and service providers, representing approximately 31.5% of the company's outstanding shares.

  • No Shareholder Approval

    The amendment and grants were approved without stockholder approval, utilizing Nasdaq Rule 5615(a)(3) for Foreign Private Issuers.

  • Potential Dilution

    The granted RSUs, valued at over $5.4 million, represent a substantial portion of the company's current market capitalization, indicating significant potential dilution for existing shareholders.


Analysis · SMX · Technology

SMX significantly expanded its 2022 Incentive Equity Plan, increasing the authorized shares by 2.3 million to a total of 4.75 million. Immediately following this, 2.3 million restricted stock units (RSUs) were granted to executive officers, directors, and service providers. These grants represent a potential dilution of approximately 31.5% of the company's current outstanding shares and are valued at over $5.4 million based on the current stock price, which is more than 50% of the company's market capitalization. The amendment and grants were approved without stockholder approval, leveraging rules for Foreign Private Issuers. This substantial increase in potential share count for compensation purposes could exert significant downward pressure on the stock.

At the time of this filing, SMX was trading at $2.35 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.65 to $27,493.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SMX - Latest Insights

SMX
Jul 17, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $16.22
Real-time Price: $17.00 info
Change: +$0.780 (+5%) info
Market Cap: $11.261M info
SMX
Jul 01, 2026, 5:26 PM EDT
Filing Type: F-3
Importance Score:
9
Price at Filing: $14.91
Real-time Price: $17.00 info
Change: +$2.09 (+14%) info
Market Cap: $11.261M info
SMX
Jul 01, 2026, 5:21 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $14.91
Real-time Price: $17.00 info
Change: +$2.09 (+14%) info
Market Cap: $11.261M info
SMX
Jun 10, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $17.00 info
Change: +$3.90 (+30%) info
Market Cap: $11.261M info
SMX
May 27, 2026, 5:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $8.00
Real-time Price: $17.00 info
Change: Reverse Stock Split info
Market Cap: $11.261M info